Bolt Biotherapeutics Inc. (BOLT)
0.52
0.00 (0.68%)
At close: Jan 15, 2025, 1:55 PM
Cashflow (Annual)
Get detailed ratio statement breakdowns, uncovering price to free cash flow ratio, price per earnings, and much more.
| Year | FY23 | FY22 | FY21 | FY20 | FY19 | FY18 |
| Net Income | -69.20M | -88.10M | -98.59M | -60.73M | -30.49M | -11.59M |
| Depreciation & Amortization | 1.85M | 1.67M | 1.19M | 611.00K | 335.00K | 302.00K |
| Stock-Based Compensation | 9.22M | 9.58M | 8.50M | 1.42M | 508.00K | 123.00K |
| Other Working Capital | -6.45M | -5.83M | 13.83M | -5.17M | 2.27M | 1.14M |
| Other Non-Cash Items | -1.54M | 3.41M | 8.56M | 13.64M | 1.04M | 153.00K |
| Deferred Income Tax | n/a | n/a | 2.76M | 34.00K | n/a | n/a |
| Change in Working Capital | -9.86M | -3.06M | 20.51M | -2.28M | 2.27M | 1.14M |
| Operating Cash Flow | -69.53M | -76.50M | -57.07M | -47.31M | -26.34M | -9.87M |
| Capital Expenditures | -206.00K | -1.95M | -2.34M | -3.26M | -508.00K | -290.00K |
| Acquisitions | n/a | -59.81M | 229.86M | 17.33M | n/a | n/a |
| Purchase of Investments | -164.99M | -180.70M | -313.38M | -33.23M | n/a | n/a |
| Sales Maturities Of Investments | 236.23M | 240.52M | 83.51M | 15.90M | n/a | n/a |
| Other Investing Acitivies | n/a | 59.81M | -229.86M | -17.33M | n/a | n/a |
| Investing Cash Flow | 71.04M | 57.86M | -232.20M | -20.59M | -508.00K | -290.00K |
| Debt Repayment | n/a | n/a | n/a | n/a | -40.00K | -39.00K |
| Common Stock Repurchased | n/a | n/a | n/a | n/a | n/a | n/a |
| Dividend Paid | n/a | n/a | n/a | n/a | n/a | n/a |
| Other Financial Acitivies | n/a | n/a | 51.90M | 39.30M | 97.26M | 38.25M |
| Financial Cash Flow | 253.00K | 503.00K | 311.11M | 39.60M | 48.63M | 19.09M |
| Net Cash Flow | 1.77M | -18.14M | 21.84M | -28.30M | 21.78M | 8.93M |
| Free Cash Flow | -69.73M | -78.46M | -59.40M | -50.57M | -26.85M | -10.16M |